tetradecanoylphorbol acetate and goserelin

tetradecanoylphorbol acetate has been researched along with goserelin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bailey, KJ; Kassis, J; Solava, J; Souto, JC; Turner, T; Wells, A	1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and goserelin

Article	Year
Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signaling. Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:4 Topics: Animals; Antineoplastic Agents, Hormonal; Cell Division; Dose-Response Relationship, Drug; Enzyme Activation; ErbB Receptors; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Prostatic Neoplasms; Protein Kinase C; Signal Transduction; Tetradecanoylphorbol Acetate; Time Factors; Tumor Cells, Cultured	2002

Article

Year

Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signaling.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:4

Topics: Animals; Antineoplastic Agents, Hormonal; Cell Division; Dose-Response Relationship, Drug; Enzyme Activation; ErbB Receptors; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Prostatic Neoplasms; Protein Kinase C; Signal Transduction; Tetradecanoylphorbol Acetate; Time Factors; Tumor Cells, Cultured

2002